Editor's note: This article has been updated to clarify that MCCPDC's partnership with Wheel began in 2024.
Specialty pharmaceutical distributor Morris & Dickson is partnering with Mark Cuban Cost Plus Drug Company (MCCPDC) and the Cost Plus Marketplace to ensure access to vital injectable medications.
MCCPDC offers consumers a broad range...
Digital therapeutic company Click Therapeutics was granted FDA marketing authorization for its prescription digital therapeutic for the preventive treatment of episodic migraines.
The de novo classification is for the company’s CT-132 offering, for which it received FDA Breakthrough Device Designation in 2022.
CT-132 is intended for the preventive treatment of episodic migraines in patients 18...
Home care cancer-focused platform Reimagine Care announced it is joining forces with healthcare system MedStar Health to integrate its on-demand oncology care platform into the health system's cancer care delivery model and assist patients with the transition from in-clinic care to the home.
Reimagine Care's patient-centered model provides patients with customized all-inclusive care from their...
According to a study published in the European Journal of Cancer, the fairness and equity of datasets for AI-driven mammogram interpretation might be jeopardized by the underrepresentation of racial and ethnic diversity.
While AI shows promise for enhancing how mammograms are interpreted, particularly in areas where resources are limited, the study's authors found warning signs regarding the...
Texas-based healthcare data analytics company MedeAnalytics announced it is collaborating with fellow healthcare data analytics firms Socially Determined and Mathematica.
The companies launched "Social Risk Insights, Measures and Outcomes," a program built on the MedeAnalytics Heath Fabric platform launched earlier this month.
Health Fabric, which is on the Snowflake AI Data Cloud, allows "...
Oncology-focused digital health company Flatiron Health announced it entered into a strategic partnership with Massive Bio, a company that helps cancer patients find and enroll in clinical trials.
Flatiron Health is an oncology-focused health technology company that offers a platform aimed at optimizing the clinical trial process, including selecting trial sites and identifying patients who are...
3D printed orthopedic implant care company restor3d announced it raised $38 million.
Summers Value Partners participated in the round along with existing and new private investors.
WHAT IT DOES
restor3d provides joint replacements and 3D printing of osseointegrative materials, AI-based planning and design automation tools.
According to the Hospital for Special Surgery in New York, "...
Biotechnology and precision medicine company Caris Life Sciences announced it raised $168 million in growth capital funding.
Caris Life Sciences has now raised $1.86 billion in capital since 2018.
Braidwell LP led the round with participation from new investors Perceptive Advisors, Woodline and Ghisallo.
Millennium Management and First Light Asset Management also participated in the round.
WHAT...
Editor's note: This article has been updated with context from Lark Health.
Chronic disease prevention and management platform Lark Health announced it will be available through CVS Caremark's Point Solutions Management program.
CVS Caremark customers will have the ability to access Lark's coaching programs, including the company's GLP-1 cost containment and obesity management offerings, through...
Genome British Columbia (Genome BC), a not-for-profit genomics research company, has secured $49 million in funding for five projects that will be conducted in British Columbia and will utilize genomics to advance personalized healthcare.
According to Genome BC, the projects are part of research funding announced in March by Genome Canada under the Canadian Precision Health Initiative (CPHI). ...
